Press-release for stocks in the health services sector for NTRA

sector : Health services symbols : NTRA

save search

Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published: 2024-04-12 (Crawled : 00:20) - prnewswire.com
AMZN | $177.79 -0.8% 9.6M

Retail Trade

| Email alert Add to watchlist
TRNS | $106.29 0.99% 2.1K

Electronic Technology

| Email alert Add to watchlist
PGNY | $32.62 2.32% 44K

Commercial Services

| Email alert Add to watchlist
VERX | $29.04 -0.03% 29K

Technology Services

| Email alert Add to watchlist
SPSC | $163.67 0.33% 15K

Technology Services

| Email alert Add to watchlist
NTRA S | $86.765 -0.59% 120K

Health Services

| Email alert Add to watchlist
CWST | $92.655 0.31% 24K

Industrial Services

| Email alert Add to watchlist
EME | $335.94 -0.04% 84K

Industrial Services

| Email alert Add to watchlist
SITE | $158.26 8.3K

Distribution Services

| Email alert Add to watchlist
CR | News | $130.585 0.92% 3.4K

Producer Manufacturing

| Email alert Add to watchlist
star update liberty growth

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11 (Crawled : 00:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| -6.39% | O: -0.36% H: 0.0% C: 0.0%
kidney publication study

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| -6.64% | O: 0.92% H: 0.26% C: -2.26%
test for heart

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| -2.51% | O: 2.12% H: 4.35% C: 2.25%
bladder positive cancer trial

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| -1.24% | O: -0.6% H: 2.8% C: 2.25%
cancer trials trial

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 0.9% | O: 0.19% H: 1.46% C: 0.48%
cancer trial

Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 1.18% | O: 0.07% H: 1.68% C: 1.65%
breast meeting

Natera to Participate in March Investor Conferences
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 18.0% | O: 11.99% H: 5.68% C: 0.89%

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 29.02% | O: -1.86% H: 2.81% C: 2.47%
conference

Liberty All-Star® Growth Fund, Inc. January 2024 Monthly Update
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SITE | $158.26 8.3K

Distribution Services

| 4.41% | O: 5.13% H: 4.44% C: 3.2%
DT 4 | $45.99 -0.58% 73K

Technology Services

| -14.48% | O: 0.85% H: 1.33% C: 0.5%
CR | News | $130.585 0.92% 3.4K

Producer Manufacturing

| 6.65% | O: 1.1% H: 1.6% C: 0.56%
WDAY S | $255.165 -0.19% 67K

Technology Services

| -13.39% | O: 0.9% H: 1.46% C: 0.95%
VERX | $29.04 -0.03% 29K

Technology Services

| 15.77% | O: 0.12% H: 3.29% C: 3.17%
TRNS | $106.29 0.99% 2.1K

Electronic Technology

| -2.02% | O: 0.84% H: 0.97% C: -0.25%
SPSC | $163.67 0.33% 15K

Technology Services

| -16.27% | O: 1.59% H: 0.96% C: -0.02%
RPD | $43.78 -0.84% 35K

Technology Services

| -25.45% | O: 1.87% H: 1.69% C: 1.25%
PGNY | $32.62 2.32% 44K

Commercial Services

| -18.45% | O: 1.62% H: 0.38% C: -0.34%
PLMR | $78.4 0.81% 21K

Finance

| 29.4% | O: 0.03% H: 6.33% C: 4.63%
NTRA S | $86.765 -0.59% 120K

Health Services

| 32.06% | O: 1.08% H: 1.37% C: 0.77%
CWST | $92.655 0.31% 24K

Industrial Services

| 7.48% | O: 0.99% H: 3.81% C: 3.77%
AMZN | $177.79 -0.8% 9.6M

Retail Trade

| 8.7% | O: 0.34% H: 1.18% C: 1.05%
AGYS 4 | $82.33 0.71% 9K

Technology Services

| -7.12% | O: 1.27% H: 1.74% C: 0.75%
star update liberty growth

New Study Validates Signatera™ in Endometrial Cancer
Published: 2024-02-05 (Crawled : 13:30) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 33.37% | O: -0.89% H: 2.74% C: 2.52%
cancer study

Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published: 2024-01-31 (Crawled : 15:30) - prnewswire.com
TMO | News | $542.82 0.24% 190K

Health Technology

| -6.02% | O: -0.67% H: 0.48% C: -4.32%
DGX | $126.8 0.71% 160K

Health Services

| -1.09% | O: 0.46% H: 0.41% C: -0.76%
LH M | $200.045 0.3% 76K

Health Services

| -11.65% | O: 0.53% H: 0.0% C: -2.31%
NVTA | $0.019 0.0% 22M

Health Services

| -95.32% | O: -0.2% H: 2.4% C: -3.7%
OPK | $1.235 0.41% 400K

Health Technology

| 21.78% | O: 0.0% H: 4.95% C: 0.99%
NTRA S | $86.765 -0.59% 120K

Health Services

| 36.86% | O: -0.76% H: 2.2% C: 0.67%
ILMN | $117.97 1.1% 160K

Health Technology

| -19.64% | O: -0.49% H: 1.17% C: -2.37%
CNTG | $0.461 13K

Commercial Services

| -58.61% | O: -0.86% H: 0.0% C: -0.43%
market

New Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 36.02% | O: -1.07% H: 1.73% C: 0.46%
lung cancer publication risk

Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies
Published: 2024-01-25 (Crawled : 13:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 37.68% | O: 0.59% H: 0.64% C: -2.09%
gastrointestinal

Invitae Completes Sale of Reproductive Health Assets to Natera
Published: 2024-01-22 (Crawled : 15:30) - biospace.com/
NVTA | $0.019 0.0% 22M

Health Services

| -95.78% | O: -2.76% H: 0.0% C: 0.0%
NTRA S | $86.765 -0.59% 120K

Health Services

| 35.57% | O: 2.3% H: 1.12% C: -2.17%
health

Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
NTRA S | $86.765 -0.59% 120K

Health Services

| 39.29% | O: -0.31% H: 5.34% C: 2.24%
year